Bank of Montreal’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.46K Hold
100
﹤0.01% 3708
2026
Q1
$5.23K Hold
100
﹤0.01% 3625
2025
Q4
$5.12K Hold
100
﹤0.01% 3486
2025
Q3
$3.89K Hold
100
﹤0.01% 3433
2025
Q2
$3.01K Hold
100
﹤0.01% 3434
2025
Q1
$2.85K Hold
100
﹤0.01% 3389
2024
Q4
$3.3K Hold
100
﹤0.01% 3423
2024
Q3
$3.73K Hold
100
﹤0.01% 3739
2024
Q2
$3.45K Hold
100
﹤0.01% 3749
2024
Q1
$3.85K Hold
100
﹤0.01% 3762
2023
Q4
$3.35K Buy
+100
New +$2.69K ﹤0.01% 3882
2021
Q1
Sell
-200
Closed -$11K 5311
2020
Q4
$11K Buy
+200
New +$9.52K ﹤0.01% 4634
2020
Q2
Sell
-494
Closed -$15K 4805
2020
Q1
$15K Buy
494
+165
+50% +$6.31K ﹤0.01% 3356
2019
Q4
$14K Hold
329
﹤0.01% 4473
2019
Q3
$10K Buy
+329
New +$11.6K ﹤0.01% 4422

Other funds holding SBIO

Bank of Montreal's SBIO Position: Q2 2026 in Review

Bank of Montreal held its ALPS Medical Breakthroughs ETF (SBIO) position steady in Q2 2026 at 100 shares worth $6.46K. The position accounts for ﹤0.01% of the portfolio, ranked #3708.

Bank of Montreal first reported a position in SBIO in Q3 2019 and has held it in 15 quarters since. The position peaked at $15K in Q1 2020. 53 funds tracked by Wall St. Rank hold SBIO as of Q2 2026.

  • Bank of Montreal held 100 shares of ALPS Medical Breakthroughs ETF worth $6.46K as of Q2 2026.
  • Bank of Montreal left its ALPS Medical Breakthroughs ETF share count unchanged in Q2 2026.
  • ALPS Medical Breakthroughs ETF made up ﹤0.01% of Bank of Montreal's portfolio in Q2 2026, its #3708 holding.
  • Bank of Montreal first reported a position in ALPS Medical Breakthroughs ETF in Q3 2019 and has held it in 15 quarters since.
  • Bank of Montreal's ALPS Medical Breakthroughs ETF position peaked at $15K in Q1 2020.
  • 53 funds tracked by Wall St. Rank held ALPS Medical Breakthroughs ETF as of Q2 2026.

Based on Bank of Montreal's 13F filing for Q2 2026, filed 12 Aug 2026.